Related Experiment Video
Updated: Dec 3, 2025

Ferric Chloride-induced Murine Thrombosis Models
Published on: September 5, 2016
Factors Affecting the Formation and Treatment of Thrombosis by Natural and Synthetic Compounds
Anna Lichota1, Eligia M Szewczyk1, Krzysztof Gwozdzinski2
1Department of Pharmaceutical Microbiology and Microbiological Diagnostic, Faculty of Pharmacy, Medical University of Lodz, 90-235 Lodz, Poland.
Insights
Venous thromboembolism (VTE), including deep vein thrombosis (DVT), is a major cardiovascular disease. This review explores factors influencing blood clot formation and discusses current and traditional treatments.
Area of Science:
- Cardiovascular Medicine
- Hematology
- Pathophysiology
Background:
- Venous thromboembolism (VTE), encompassing deep vein thrombosis (DVT) and pulmonary embolism (PE), is a significant cause of morbidity and mortality.
- DVT involves blood clot formation in deep veins, leading to altered blood flow and cellular responses.
- Thrombosis is the third leading cardiovascular disease globally.
Purpose of the Study:
- To review the factors influencing hemostatic disorders and blood clot formation.
- To discuss the mechanisms of thrombosis, including cellular and molecular players.
- To examine current and traditional therapeutic strategies for VTE.
Main Methods:
- Literature review of factors affecting hemostasis and thrombosis.
- Analysis of mechanisms involving hypoxia, endothelial cells, platelets, and neutrophils.
- Review of anticoagulant and antiplatelet drug actions.
- Exploration of natural anticoagulants from plant sources.
Main Results:
- Blood clot formation involves fibrin, platelets, and blood cells, influenced by factors like hypoxia and reactive oxygen species (ROS).
- Endothelial cells, platelets, and neutrophils play critical roles in thrombosis pathogenesis.
- Anticoagulants and antiplatelet drugs target coagulation factors and platelet activation.
- Natural anticoagulants from traditional Eastern medicine offer potential therapeutic avenues.
Conclusions:
- While significant progress has been made, the pathogenesis of thrombosis requires further clarification.
- A comprehensive understanding of thrombosis mechanisms is crucial for developing effective treatments.
- Investigating natural anticoagulants may reveal novel therapeutic targets for VTE prevention and management.
Abstract:
Venous thromboembolism (VTE) refers to deep vein thrombosis (DVT), whose consequence may be a pulmonary embolism (PE). Thrombosis is associated with significant morbidity and mortality and is the third most common cardiovascular disease after myocardial infarction and stroke. DVT is associated with the formation of a blood clot in a deep vein in the body. Thrombosis promotes slowed blood flow, hypoxia, cell activation, and the associated release of many active substances involved in blood clot formation. All thrombi which adhere to endothelium consist of fibrin, platelets, and trapped red and white blood cells. In this review, we summarise the impact of various factors affecting haemostatic disorders leading to blood clot formation. The paper discusses the causes of thrombosis, the mechanism of blood clot formation, and factors such as hypoxia, the involvement of endothelial cells (ECs), and the activation of platelets and neutrophils along with the effects of bacteria and reactive oxygen species (ROS). Mechanisms related to the action of anticoagulants affecting coagulation factors including antiplatelet drugs have also been discussed. However, many aspects related to the pathogenesis of thrombosis still need to be clarified. A review of the drugs used to treat and prevent thrombosis and natural anticoagulants that occur in the plant world and are traditionally used in Far Eastern medicine has also been carried out.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Clot Retraction and Fibrinolysis
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis I: Introduction
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.

